Literature DB >> 31515630

Infrequent tacrolimus-induced nephrotoxicity in French patients with steroid-dependent nephrotic syndrome.

Jean Daniel Delbet1,2, Bilal Aoun3, David Buob2,4, Jad Degheili5, Isabelle Brocheriou2,4, Tim Ulinski6,7,8.   

Abstract

BACKGROUND: Chronic nephrotoxicity with potentially irreversible lesions is a major concern regarding calcineurin inhibitor (CNI) treatment in children with severe forms of idiopathic nephrotic syndrome (INS). CASE-DIAGNOSIS/TREATMENT: We retrospectively included all children on CNI for steroid-dependent INS with a duration of CNI treatment of more than 1 year. Only patients in whom CNI could not be replaced by mycophenolate mofetil were included. All included patients underwent a kidney biopsy. All results were expressed as median and range. Twenty-one children (6 girls) were included. Age at disease onset was 49 (29-66) months and treatment duration on CNI was 30 (20-45) months. Age at kidney biopsy was 108 (78-170) months. Number of relapses was 7 (3-9) since disease onset. Serum creatinine level was transiently and moderately increased in two patients. Kidney biopsy revealed minimal change disease in 20/21 patients and focal segmental glomerulosclerosis in 1/21. Evidence for chronic CNI nephrotoxicity was found in one patient revealed by arteriolar hyalinosis and fibrosis in 50% of glomeruli.
CONCLUSIONS: CNI-induced chronic nephrotoxicity was infrequent. In patients who require long-term and/or high-dose CNI treatment, kidney biopsies might be useful to exclude chronic CNI-induced lesions.

Entities:  

Keywords:  Children; Cyclosporine; Idiopathic nephrotic syndrome; Nephrotoxicity; Tacrolimus

Year:  2019        PMID: 31515630     DOI: 10.1007/s00467-019-04343-2

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  15 in total

1.  Long-term cyclosporine therapy for pediatric nephrotic syndrome: a clinical and histologic analysis.

Authors:  M J Gregory; W E Smoyer; A Sedman; D B Kershaw; R P Valentini; K Johnson; T E Bunchman
Journal:  J Am Soc Nephrol       Date:  1996-04       Impact factor: 10.121

Review 2.  Treatment of steroid-sensitive nephrotic syndrome: new guidelines from KDIGO.

Authors:  Rebecca M Lombel; Debbie S Gipson; Elisabeth M Hodson
Journal:  Pediatr Nephrol       Date:  2012-10-03       Impact factor: 3.714

3.  Calcineurin Inhibitor Nephrotoxicity Through the Lens of Longitudinal Histology: Comparison of Cyclosporine and Tacrolimus Eras.

Authors:  Brian J Nankivell; Chow H PʼNg; Philip J OʼConnell; Jeremy R Chapman
Journal:  Transplantation       Date:  2016-08       Impact factor: 4.939

4.  Nephrotoxicity in children with frequently relapsing nephrotic syndrome receiving long-term cyclosporine treatment.

Authors:  Yuko Hamasaki; Fumiyo Komaki; Kenji Ishikura; Riku Hamada; Tomoyuki Sakai; Hiroshi Hataya; Kentaro Ogata; Takashi Ando; Masataka Honda
Journal:  Pediatr Nephrol       Date:  2017-04-04       Impact factor: 3.714

5.  Long-term clinical and pathological effects of cyclosporin in children with nephrosis.

Authors:  M G Seikaly; H Prashner; B Nolde-Hurlbert; R Browne
Journal:  Pediatr Nephrol       Date:  2000-03       Impact factor: 3.714

6.  Risk factors for cyclosporine-induced tubulointerstitial lesions in children with minimal change nephrotic syndrome.

Authors:  Kazumoto Iijima; Kiyoshi Hamahira; Ryojiro Tanaka; Akiko Kobayashi; Kandai Nozu; Hajime Nakamura; Norishige Yoshikawa
Journal:  Kidney Int       Date:  2002-05       Impact factor: 10.612

7.  Early conversion from cyclosporine to tacrolimus increases renal graft function in chronic allograft nephropathy at BANFF stages I and II.

Authors:  Thorsten Marcard; Katrin Ivens; Bernd Grabensee; Reinhart Willers; Udo Helmchen; Lars Christian Rump; Cornelia Blume
Journal:  Transpl Int       Date:  2008-08-05       Impact factor: 3.782

8.  Tacrolimus as a steroid-sparing agent for adults with steroid-dependent minimal change nephrotic syndrome.

Authors:  Xiayu Li; Heng Li; Jianghua Chen; Qiang He; Rong Lv; Weiqin Lin; Qun Li; Xuelin He; Lihui Qu; Wang Suya
Journal:  Nephrol Dial Transplant       Date:  2007-10-01       Impact factor: 5.992

9.  Effect of cyclosporin A on glomerular filtration rate in children with minimal change nephrotic syndrome.

Authors:  S A Hulton; L Jadresic; V Shah; R S Trompeter; M J Dillon; T M Barratt
Journal:  Pediatr Nephrol       Date:  1994-08       Impact factor: 3.714

10.  Calcineurin inhibitor induced nephrotoxicity in steroid resistant nephrotic syndrome.

Authors:  A Sinha; A Sharma; A Mehta; R Gupta; A Gulati; P Hari; A K Dinda; A Bagga
Journal:  Indian J Nephrol       Date:  2013-01
View more
  4 in total

1.  Steroid Sensitive Nephrotic Syndrome: Revised Guidelines.

Authors:  Aditi Sinha; Arvind Bagga; Sushmita Banerjee; Kirtisudha Mishra; Amarjeet Mehta; Indira Agarwal; Susan Uthup; Abhijeet Saha; Om Prakash Mishra
Journal:  Indian Pediatr       Date:  2021-03-20       Impact factor: 1.411

2.  Effects of Huaiqihuang Granules Adjuvant Therapy in Children with Primary Nephrotic Syndrome.

Authors:  Ping Zhou; Qiong Xiao; Lan Chen; Zhi-Jie Zou; Yu-Qing Wang; Lin Zhu; Hai-Yan Yu; Cheng-Guang Zhao; Yu-Bin Wu; Xuan-Yi Du
Journal:  Open Life Sci       Date:  2019-12-31       Impact factor: 0.938

3.  Efficacy of rituximab versus tacrolimus in difficult-to-treat steroid-sensitive nephrotic syndrome: an open-label pilot randomized controlled trial.

Authors:  Georgie Mathew; Aditi Sinha; Aijaz Ahmed; Neetu Grewal; Priyanka Khandelwal; Pankaj Hari; Arvind Bagga
Journal:  Pediatr Nephrol       Date:  2022-03-14       Impact factor: 3.651

Review 4.  Current understandings in treating children with steroid-resistant nephrotic syndrome.

Authors:  Jae Il Shin; Jun Oh; Jiwon M Lee; Andreas Kronbichler
Journal:  Pediatr Nephrol       Date:  2020-02-21       Impact factor: 3.714

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.